Events

June 27, 2022

APIM Therapeutics will be attending the ESMO Congress 2022 held in Paris, France between September 9-13. 

April 30, 2021

APIM Therapeutics will be attending the 2021 ASCO Annual Meeting, Fri, Jun 4, 2021 – Tue, Jun 8, 2021.

February 9, 2021

APIM Therapeutics will be participating at the virtual Biopharma CxO Roundtable entitled: “Clinical trial acceleration — 500 days faster from start to finish” organized by McKinsey & Company and Hadean Ventures on February 16th, 2021. More information on the roundtable can be found here.

March 14, 2019

APIM Therapeutics will be participating at the BioEurope Spring Partnering meeting, in Vienna, Austria (March 25-27, 2019).

March 6, 2017

APIM Therapeutics will be participating at BioEurope Spring Partnering meeting, in Barcelona, Spain (March 20-22, 2017).

October 25, 2016

APIM Therapeutics will be participating at BioEurope Partnering meeting, in Cologne, Germany (November 7-9, 2016).

August 25, 2016

APIM Therapeutics will be participating at the Nordic Life Sciences Days conference in Stockholm (September 14-15, 2016). A presentation during the Biotechnology Track: R&D Services/Therapeutics & Diagnostics/Others will be given on Sept. 14, 17.15.

April 11, 2016

APIM Therapeutics will be participating at the BioTrinity 2016 and BioEquity 2016 partnering meetings held on April 25-27 and May 10-11, 2016 in London and Copenhagen, respectively.

March 23, 2016

APIM Therapeutics's CSO and NTNU Professor Marit Otterlei presents latest results obtained with ATX-101 in preclinical efficacy models in the 14th International Congress on Targeted Anticancer Therapies, 21-23 March, 2016, Washington, USA. A copy of the poster presented is available here.

May 7, 2015

APIM Therapeutics's CEO, Kostas Alevizopoulos, will be presenting the company's latest development plans in the BioTrinity Investor Conference in London (May 11-13, 2015).

May 1, 2013

APIM Therapeutics will be presenting an abstract entitled "Increased efficacy of intravesical chemotherapy in an orthotopic rat bladder cancer model by targeting PCNA with the novel synthetic peptide drug ATX-101" at the Annual Meeting of the American Association of Urology held in San Diego in May 4-8, 2013.

February 28, 2013

APIM Therapeutics will be presenting an abstract entitled "Targeting DNA repair mechanisms increases efficiency of intravesical chemotherapy in an orthotopic rat bladder cancer model" at the 28th Annual European Urology Association Meeting held in Milan in March 15-19, 2013.

August 16, 2012

APIM Therapeutics has been selected to present at the 12th Biotech In Europe Investor Forum. The conference, which takes place in October 1-2, 2012 in Zurich, brings together venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders.